Literature DB >> 24000146

Altered glucose metabolism in Harvey-ras transformed MCF10A cells.

Wei Zheng1, Fariba Tayyari, G A Nagana Gowda, Daniel Raftery, Eric S McLamore, D Marshall Porterfield, Shawn S Donkin, Brian Bequette, Dorothy Teegarden.   

Abstract

Metabolic reprogramming that alters the utilization of glucose including the "Warburg effect" is critical in the development of a tumorigenic phenotype. However, the effects of the Harvey-ras (H-ras) oncogene on cellular energy metabolism during mammary carcinogenesis are not known. The purpose of this study was to determine the effect of H-ras transformation on glucose metabolism using the untransformed MCF10A and H-ras oncogene transfected (MCF10A-ras) human breast epithelial cells, a model for early breast cancer progression. We measured the metabolite fluxes at the cell membrane by a selective micro-biosensor, [(13)C6 ]glucose flux by (13)C-mass isotopomer distribution analysis of media metabolites, intracellular metabolite levels by NMR, and gene expression of glucose metabolism enzymes by quantitative PCR. Results from these studies indicated that MCF10A-ras cells exhibited enhanced glycolytic activity and lactate production, decreased glucose flux through the tricarboxylic acid (TCA) cycle, as well as an increase in the utilization of glucose in the pentose phosphate pathway (PPP). These results provide evidence for a role of H-ras oncogene in the metabolic reprogramming of MCF10A cells during early mammary carcinogenesis.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  breast cancer; glucose; metabolism; ras

Mesh:

Substances:

Year:  2013        PMID: 24000146      PMCID: PMC4467525          DOI: 10.1002/mc.22079

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  48 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Fermentanomics: monitoring mammalian cell cultures with NMR spectroscopy.

Authors:  Scott A Bradley; Anli Ouyang; Jennifer Purdie; Tim A Smitka; Tongtong Wang; Andreas Kaerner
Journal:  J Am Chem Soc       Date:  2010-07-21       Impact factor: 15.419

3.  Expression of facilitative glucose transporter 1 mRNA in colon cancer was not regulated by k-ras.

Authors:  Y Noguchi; T Okamoto; D Marat; T Yoshikawa; A Saitoh; C Doi; K Fukuzawa; A Tsuburaya; S Satoh; T Ito
Journal:  Cancer Lett       Date:  2000-06-30       Impact factor: 8.679

4.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

5.  Early detection of recurrent breast cancer using metabolite profiling.

Authors:  Vincent M Asiago; Leiddy Z Alvarado; Narasimhamurthy Shanaiah; G A Nagana Gowda; Kwadwo Owusu-Sarfo; Robert A Ballas; Daniel Raftery
Journal:  Cancer Res       Date:  2010-10-19       Impact factor: 12.701

Review 6.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

7.  ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis.

Authors:  Kaori Ishikawa; Keizo Takenaga; Miho Akimoto; Nobuko Koshikawa; Aya Yamaguchi; Hirotake Imanishi; Kazuto Nakada; Yoshio Honma; Jun-Ichi Hayashi
Journal:  Science       Date:  2008-04-03       Impact factor: 47.728

Review 8.  Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells.

Authors:  Olivier Feron
Journal:  Radiother Oncol       Date:  2009-07-13       Impact factor: 6.280

Review 9.  Tumor suppressors and cell metabolism: a recipe for cancer growth.

Authors:  Russell G Jones; Craig B Thompson
Journal:  Genes Dev       Date:  2009-03-01       Impact factor: 11.361

10.  Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma.

Authors:  Tsann-Long Hwang; Ying Liang; Kuan-Yi Chien; Jau-Song Yu
Journal:  Proteomics       Date:  2006-04       Impact factor: 3.984

View more
  13 in total

1.  1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cell.

Authors:  Xuanzhu Zhou; Wei Zheng; G A Nagana Gowda; Daniel Raftery; Shawn S Donkin; Brian Bequette; Dorothy Teegarden
Journal:  J Steroid Biochem Mol Biol       Date:  2016-05-03       Impact factor: 4.292

Review 2.  Proteolytic regulation of mitochondrial dynamics.

Authors:  Jonathan V Dietz; Iryna Bohovych; Martonio Ponte Viana; Oleh Khalimonchuk
Journal:  Mitochondrion       Date:  2019-04-25       Impact factor: 4.160

Review 3.  The importance of accurately correcting for the natural abundance of stable isotopes.

Authors:  Firas S Midani; Michelle L Wynn; Santiago Schnell
Journal:  Anal Biochem       Date:  2017-01-11       Impact factor: 3.365

Review 4.  The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling.

Authors:  Wilhelm Engström; Philippa Darbre; Staffan Eriksson; Linda Gulliver; Tove Hultman; Michalis V Karamouzis; James E Klaunig; Rekha Mehta; Kim Moorwood; Thomas Sanderson; Hideko Sone; Pankaj Vadgama; Gerard Wagemaker; Andrew Ward; Neetu Singh; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Anna Maria Colacci; Monica Vaccari; Chiara Mondello; A Ivana Scovassi; Jayadev Raju; Roslida A Hamid; Lorenzo Memeo; Stefano Forte; Rabindra Roy; Jordan Woodrick; Hosni K Salem; Elizabeth P Ryan; Dustin G Brown; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

5.  Inhibition of pyruvate carboxylase by 1α,25-dihydroxyvitamin D promotes oxidative stress in early breast cancer progression.

Authors:  Tomasz Wilmanski; Xuanzhu Zhou; Wei Zheng; Aparna Shinde; Shawn S Donkin; Michael Wendt; John R Burgess; Dorothy Teegarden
Journal:  Cancer Lett       Date:  2017-10-09       Impact factor: 8.679

6.  Epigenetic and metabolic interplay in cutaneous squamous cell carcinoma.

Authors:  Gina Pacella; Brian C Capell
Journal:  Exp Dermatol       Date:  2021-04-22       Impact factor: 3.960

7.  Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in Cancer.

Authors:  Matthew Ruffalo; Mehmet Koyutürk; Roded Sharan
Journal:  PLoS Comput Biol       Date:  2015-12-18       Impact factor: 4.475

8.  Metabolomic characterisation of the effects of oncogenic PIK3CA transformation in a breast epithelial cell line.

Authors:  Chung-Ho E Lau; Gregory D Tredwell; James K Ellis; Eric W-F Lam; Hector C Keun
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

9.  Mice with an Oncogenic HRAS Mutation are Resistant to High-Fat Diet-Induced Obesity and Exhibit Impaired Hepatic Energy Homeostasis.

Authors:  Daiju Oba; Shin-Ichi Inoue; Sachiko Miyagawa-Tomita; Yasumi Nakashima; Tetsuya Niihori; Seiji Yamaguchi; Yoichi Matsubara; Yoko Aoki
Journal:  EBioMedicine       Date:  2017-12-06       Impact factor: 8.143

Review 10.  mTOR Signalling in Head and Neck Cancer: Heads Up.

Authors:  Fiona H Tan; Yuchen Bai; Pierre Saintigny; Charbel Darido
Journal:  Cells       Date:  2019-04-09       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.